id	sid	tid	token	lemma	pos
cord-276423-8rwmrl0l	1	1	key	key	JJ
cord-276423-8rwmrl0l	1	2	:	:	:
cord-276423-8rwmrl0l	1	3	cord-276423	cord-276423	JJ
cord-276423-8rwmrl0l	1	4	-	-	HYPH
cord-276423-8rwmrl0l	1	5	8rwmrl0l	8rwmrl0l	NNS
cord-276423-8rwmrl0l	1	6	authors	author	NNS
cord-276423-8rwmrl0l	1	7	:	:	:
cord-276423-8rwmrl0l	1	8	Mota	Mota	NNP
cord-276423-8rwmrl0l	1	9	,	,	,
cord-276423-8rwmrl0l	1	10	Pedro	Pedro	NNP
cord-276423-8rwmrl0l	1	11	title	title	NN
cord-276423-8rwmrl0l	1	12	:	:	:
cord-276423-8rwmrl0l	1	13	Avoiding	avoid	VBG
cord-276423-8rwmrl0l	1	14	a	a	DT
cord-276423-8rwmrl0l	1	15	new	new	JJ
cord-276423-8rwmrl0l	1	16	epidemic	epidemic	NN
cord-276423-8rwmrl0l	1	17	during	during	IN
cord-276423-8rwmrl0l	1	18	a	a	DT
cord-276423-8rwmrl0l	1	19	pandemic	pandemic	NN
cord-276423-8rwmrl0l	1	20	:	:	:
cord-276423-8rwmrl0l	1	21	the	the	DT
cord-276423-8rwmrl0l	1	22	importance	importance	NN
cord-276423-8rwmrl0l	1	23	of	of	IN
cord-276423-8rwmrl0l	1	24	assessing	assess	VBG
cord-276423-8rwmrl0l	1	25	the	the	DT
cord-276423-8rwmrl0l	1	26	risk	risk	NN
cord-276423-8rwmrl0l	1	27	of	of	IN
cord-276423-8rwmrl0l	1	28	substance	substance	NN
cord-276423-8rwmrl0l	1	29	use	use	NN
cord-276423-8rwmrl0l	1	30	disorders	disorder	NNS
cord-276423-8rwmrl0l	1	31	in	in	IN
cord-276423-8rwmrl0l	1	32	the	the	DT
cord-276423-8rwmrl0l	1	33	COVID-19	COVID-19	NNP
cord-276423-8rwmrl0l	1	34	era	era	NN
cord-276423-8rwmrl0l	1	35	.	.	.
cord-276423-8rwmrl0l	2	1	date	date	NN
cord-276423-8rwmrl0l	2	2	:	:	:
cord-276423-8rwmrl0l	2	3	2020	2020	CD
cord-276423-8rwmrl0l	2	4	-	-	HYPH
cord-276423-8rwmrl0l	2	5	05	05	CD
cord-276423-8rwmrl0l	2	6	-	-	HYPH
cord-276423-8rwmrl0l	2	7	28	28	CD
cord-276423-8rwmrl0l	2	8	journal	journal	NN
cord-276423-8rwmrl0l	2	9	:	:	:
cord-276423-8rwmrl0l	3	1	Psychiatry	psychiatry	NN
cord-276423-8rwmrl0l	3	2	Res	Res	NNP
cord-276423-8rwmrl0l	3	3	DOI	DOI	NNP
cord-276423-8rwmrl0l	3	4	:	:	:
cord-276423-8rwmrl0l	3	5	10.1016	10.1016	CD
cord-276423-8rwmrl0l	3	6	/	/	SYM
cord-276423-8rwmrl0l	3	7	j.psychres.2020.113142	j.psychres.2020.113142	NN
cord-276423-8rwmrl0l	3	8	sha	sha	NNP
cord-276423-8rwmrl0l	3	9	:	:	:
cord-276423-8rwmrl0l	4	1	614bdc20634e2ba70040a0121c88176dfe0fb949	614bdc20634e2ba70040a0121c88176dfe0fb949	RB
cord-276423-8rwmrl0l	4	2	doc_id	doc_id	NNP
cord-276423-8rwmrl0l	4	3	:	:	:
cord-276423-8rwmrl0l	4	4	276423	276423	CD
cord-276423-8rwmrl0l	4	5	cord_uid	cord_uid	NNS
cord-276423-8rwmrl0l	4	6	:	:	:
cord-276423-8rwmrl0l	5	1	8rwmrl0l	8rwmrl0l	NNP
cord-276423-8rwmrl0l	5	2	nan	nan	NNP
cord-276423-8rwmrl0l	6	1	On	on	IN
cord-276423-8rwmrl0l	6	2	March	March	NNP
cord-276423-8rwmrl0l	6	3	11	11	CD
cord-276423-8rwmrl0l	6	4	,	,	,
cord-276423-8rwmrl0l	6	5	2020	2020	CD
cord-276423-8rwmrl0l	6	6	,	,	,
cord-276423-8rwmrl0l	6	7	the	the	DT
cord-276423-8rwmrl0l	6	8	World	World	NNP
cord-276423-8rwmrl0l	6	9	Health	Health	NNP
cord-276423-8rwmrl0l	6	10	Organization	Organization	NNP
cord-276423-8rwmrl0l	6	11	classified	classify	VBD
cord-276423-8rwmrl0l	6	12	the	the	DT
cord-276423-8rwmrl0l	6	13	public	public	JJ
cord-276423-8rwmrl0l	6	14	health	health	NN
cord-276423-8rwmrl0l	6	15	emergency	emergency	NN
cord-276423-8rwmrl0l	6	16	caused	cause	VBN
cord-276423-8rwmrl0l	6	17	by	by	IN
cord-276423-8rwmrl0l	6	18	COVID-19	COVID-19	NNP
cord-276423-8rwmrl0l	6	19	as	as	IN
cord-276423-8rwmrl0l	6	20	a	a	DT
cord-276423-8rwmrl0l	6	21	pandemic	pandemic	NN
cord-276423-8rwmrl0l	6	22	,	,	,
cord-276423-8rwmrl0l	6	23	causing	cause	VBG
cord-276423-8rwmrl0l	6	24	significant	significant	JJ
cord-276423-8rwmrl0l	6	25	changes	change	NNS
cord-276423-8rwmrl0l	6	26	in	in	IN
cord-276423-8rwmrl0l	6	27	people	people	NNS
cord-276423-8rwmrl0l	6	28	's	's	POS
cord-276423-8rwmrl0l	6	29	daily	daily	JJ
cord-276423-8rwmrl0l	6	30	lives	life	NNS
cord-276423-8rwmrl0l	6	31	and	and	CC
cord-276423-8rwmrl0l	6	32	a	a	DT
cord-276423-8rwmrl0l	6	33	devastating	devastating	JJ
cord-276423-8rwmrl0l	6	34	impact	impact	NN
cord-276423-8rwmrl0l	6	35	on	on	IN
cord-276423-8rwmrl0l	6	36	the	the	DT
cord-276423-8rwmrl0l	6	37	economy	economy	NN
cord-276423-8rwmrl0l	6	38	,	,	,
cord-276423-8rwmrl0l	6	39	accompanied	accompany	VBN
cord-276423-8rwmrl0l	6	40	by	by	IN
cord-276423-8rwmrl0l	6	41	a	a	DT
cord-276423-8rwmrl0l	6	42	profound	profound	JJ
cord-276423-8rwmrl0l	6	43	overhaul	overhaul	NN
cord-276423-8rwmrl0l	6	44	of	of	IN
cord-276423-8rwmrl0l	6	45	social	social	JJ
cord-276423-8rwmrl0l	6	46	structures	structure	NNS
cord-276423-8rwmrl0l	6	47	and	and	CC
cord-276423-8rwmrl0l	6	48	health	health	NN
cord-276423-8rwmrl0l	6	49	systems	system	NNS
cord-276423-8rwmrl0l	6	50	.	.	.
cord-276423-8rwmrl0l	7	1	From	from	IN
cord-276423-8rwmrl0l	7	2	its	-PRON-	PRP$
cord-276423-8rwmrl0l	7	3	expected	expect	VBN
cord-276423-8rwmrl0l	7	4	major	major	JJ
cord-276423-8rwmrl0l	7	5	impact	impact	NN
cord-276423-8rwmrl0l	7	6	on	on	IN
cord-276423-8rwmrl0l	7	7	mental	mental	JJ
cord-276423-8rwmrl0l	7	8	health	health	NN
cord-276423-8rwmrl0l	7	9	,	,	,
cord-276423-8rwmrl0l	7	10	social	social	JJ
cord-276423-8rwmrl0l	7	11	distance	distance	NN
cord-276423-8rwmrl0l	7	12	measures	measure	NNS
cord-276423-8rwmrl0l	7	13	imposed	impose	VBN
cord-276423-8rwmrl0l	7	14	worldwide	worldwide	RB
cord-276423-8rwmrl0l	7	15	are	be	VBP
cord-276423-8rwmrl0l	7	16	themselves	-PRON-	PRP
cord-276423-8rwmrl0l	7	17	risk	risk	NN
cord-276423-8rwmrl0l	7	18	factors	factor	NNS
cord-276423-8rwmrl0l	7	19	for	for	IN
cord-276423-8rwmrl0l	7	20	different	different	JJ
cord-276423-8rwmrl0l	7	21	mental	mental	JJ
cord-276423-8rwmrl0l	7	22	health	health	NN
cord-276423-8rwmrl0l	7	23	problems	problem	NNS
cord-276423-8rwmrl0l	7	24	,	,	,
cord-276423-8rwmrl0l	7	25	including	include	VBG
cord-276423-8rwmrl0l	7	26	suicide	suicide	NN
cord-276423-8rwmrl0l	7	27	and	and	CC
cord-276423-8rwmrl0l	7	28	self	self	NN
cord-276423-8rwmrl0l	7	29	-	-	HYPH
cord-276423-8rwmrl0l	7	30	harm	harm	NN
cord-276423-8rwmrl0l	7	31	,	,	,
cord-276423-8rwmrl0l	7	32	alcohol	alcohol	NN
cord-276423-8rwmrl0l	7	33	and	and	CC
cord-276423-8rwmrl0l	7	34	substance	substance	NN
cord-276423-8rwmrl0l	7	35	misuse	misuse	NN
cord-276423-8rwmrl0l	7	36	,	,	,
cord-276423-8rwmrl0l	7	37	gambling	gambling	NN
cord-276423-8rwmrl0l	7	38	and	and	CC
cord-276423-8rwmrl0l	7	39	domestic	domestic	JJ
cord-276423-8rwmrl0l	7	40	/	/	SYM
cord-276423-8rwmrl0l	7	41	child	child	NN
cord-276423-8rwmrl0l	7	42	abuse	abuse	NN
cord-276423-8rwmrl0l	7	43	.	.	.
cord-276423-8rwmrl0l	8	1	Since	since	IN
cord-276423-8rwmrl0l	8	2	quarantined	quarantine	VBN
cord-276423-8rwmrl0l	8	3	people	people	NNS
cord-276423-8rwmrl0l	8	4	may	may	MD
cord-276423-8rwmrl0l	8	5	experience	experience	VB
cord-276423-8rwmrl0l	8	6	boredom	boredom	NN
cord-276423-8rwmrl0l	8	7	,	,	,
cord-276423-8rwmrl0l	8	8	loneliness	loneliness	NN
cord-276423-8rwmrl0l	8	9	,	,	,
cord-276423-8rwmrl0l	8	10	anger	anger	NN
cord-276423-8rwmrl0l	8	11	,	,	,
cord-276423-8rwmrl0l	8	12	depression	depression	NN
cord-276423-8rwmrl0l	8	13	,	,	,
cord-276423-8rwmrl0l	8	14	anxiety	anxiety	NN
cord-276423-8rwmrl0l	8	15	,	,	,
cord-276423-8rwmrl0l	8	16	despair	despair	NN
cord-276423-8rwmrl0l	8	17	and	and	CC
cord-276423-8rwmrl0l	8	18	insomnia	insomnia	NN
cord-276423-8rwmrl0l	8	19	,	,	,
cord-276423-8rwmrl0l	8	20	providers	provider	NNS
cord-276423-8rwmrl0l	8	21	should	should	MD
cord-276423-8rwmrl0l	8	22	be	be	VB
cord-276423-8rwmrl0l	8	23	alert	alert	JJ
cord-276423-8rwmrl0l	8	24	to	to	IN
cord-276423-8rwmrl0l	8	25	potential	potential	JJ
cord-276423-8rwmrl0l	8	26	increases	increase	NNS
cord-276423-8rwmrl0l	8	27	in	in	IN
cord-276423-8rwmrl0l	8	28	substance	substance	NN
cord-276423-8rwmrl0l	8	29	use	use	NN
cord-276423-8rwmrl0l	8	30	to	to	TO
cord-276423-8rwmrl0l	8	31	alleviate	alleviate	VB
cord-276423-8rwmrl0l	8	32	these	these	DT
cord-276423-8rwmrl0l	8	33	negative	negative	JJ
cord-276423-8rwmrl0l	8	34	feelings	feeling	NNS
cord-276423-8rwmrl0l	8	35	,	,	,
cord-276423-8rwmrl0l	8	36	particularly	particularly	RB
cord-276423-8rwmrl0l	8	37	among	among	IN
cord-276423-8rwmrl0l	8	38	vulnerable	vulnerable	JJ
cord-276423-8rwmrl0l	8	39	patients	patient	NNS
cord-276423-8rwmrl0l	8	40	like	like	IN
cord-276423-8rwmrl0l	8	41	those	those	DT
cord-276423-8rwmrl0l	8	42	with	with	IN
cord-276423-8rwmrl0l	8	43	a	a	DT
cord-276423-8rwmrl0l	8	44	substance	substance	NN
cord-276423-8rwmrl0l	8	45	use	use	NN
cord-276423-8rwmrl0l	8	46	disorder	disorder	NN
cord-276423-8rwmrl0l	8	47	(	(	-LRB-
cord-276423-8rwmrl0l	8	48	SUD	SUD	NNP
cord-276423-8rwmrl0l	8	49	)	)	-RRB-
cord-276423-8rwmrl0l	8	50	.	.	.
cord-276423-8rwmrl0l	9	1	Globally	globally	RB
cord-276423-8rwmrl0l	9	2	,	,	,
cord-276423-8rwmrl0l	9	3	SUDs	sud	NNS
cord-276423-8rwmrl0l	9	4	are	be	VBP
cord-276423-8rwmrl0l	9	5	estimated	estimate	VBN
cord-276423-8rwmrl0l	9	6	to	to	TO
cord-276423-8rwmrl0l	9	7	have	have	VB
cord-276423-8rwmrl0l	9	8	a	a	DT
cord-276423-8rwmrl0l	9	9	prevalence	prevalence	NN
cord-276423-8rwmrl0l	9	10	of	of	IN
cord-276423-8rwmrl0l	9	11	100.4	100.4	CD
cord-276423-8rwmrl0l	9	12	million	million	CD
cord-276423-8rwmrl0l	9	13	persons	person	NNS
cord-276423-8rwmrl0l	9	14	for	for	IN
cord-276423-8rwmrl0l	9	15	alcohol	alcohol	NN
cord-276423-8rwmrl0l	9	16	,	,	,
cord-276423-8rwmrl0l	9	17	22.1	22.1	CD
cord-276423-8rwmrl0l	9	18	million	million	CD
cord-276423-8rwmrl0l	9	19	for	for	IN
cord-276423-8rwmrl0l	9	20	cannabis	cannabis	NN
cord-276423-8rwmrl0l	9	21	and	and	CC
cord-276423-8rwmrl0l	9	22	26.8	26.8	CD
cord-276423-8rwmrl0l	9	23	million	million	CD
cord-276423-8rwmrl0l	9	24	for	for	IN
cord-276423-8rwmrl0l	9	25	opioids	opioid	NNS
cord-276423-8rwmrl0l	9	26	(	(	-LRB-
cord-276423-8rwmrl0l	9	27	GBD	GBD	NNP
cord-276423-8rwmrl0l	9	28	2016	2016	CD
cord-276423-8rwmrl0l	9	29	Alcohol	alcohol	NN
cord-276423-8rwmrl0l	9	30	and	and	CC
cord-276423-8rwmrl0l	9	31	Drug	Drug	NNP
cord-276423-8rwmrl0l	9	32	Use	Use	NNP
cord-276423-8rwmrl0l	9	33	Collaborators	Collaborators	NNPS
cord-276423-8rwmrl0l	9	34	,	,	,
cord-276423-8rwmrl0l	9	35	2018	2018	CD
cord-276423-8rwmrl0l	9	36	)	)	-RRB-
cord-276423-8rwmrl0l	9	37	,	,	,
cord-276423-8rwmrl0l	9	38	and	and	CC
cord-276423-8rwmrl0l	9	39	social	social	JJ
cord-276423-8rwmrl0l	9	40	and	and	CC
cord-276423-8rwmrl0l	9	41	mental	mental	JJ
cord-276423-8rwmrl0l	9	42	health	health	NN
cord-276423-8rwmrl0l	9	43	support	support	NN
cord-276423-8rwmrl0l	9	44	is	be	VBZ
cord-276423-8rwmrl0l	9	45	crucial	crucial	JJ
cord-276423-8rwmrl0l	9	46	for	for	IN
cord-276423-8rwmrl0l	9	47	people	people	NNS
cord-276423-8rwmrl0l	9	48	trying	try	VBG
cord-276423-8rwmrl0l	9	49	to	to	TO
cord-276423-8rwmrl0l	9	50	recover	recover	VB
cord-276423-8rwmrl0l	9	51	from	from	IN
cord-276423-8rwmrl0l	9	52	SUD	SUD	NNP
cord-276423-8rwmrl0l	9	53	,	,	,
cord-276423-8rwmrl0l	9	54	whereas	whereas	IN
cord-276423-8rwmrl0l	9	55	social	social	JJ
cord-276423-8rwmrl0l	9	56	isolation	isolation	NN
cord-276423-8rwmrl0l	9	57	is	be	VBZ
cord-276423-8rwmrl0l	9	58	a	a	DT
cord-276423-8rwmrl0l	9	59	risk	risk	NN
cord-276423-8rwmrl0l	9	60	factor	factor	NN
cord-276423-8rwmrl0l	9	61	for	for	IN
cord-276423-8rwmrl0l	9	62	relapse	relapse	NN
cord-276423-8rwmrl0l	9	63	.	.	.
cord-276423-8rwmrl0l	10	1	As	as	IN
cord-276423-8rwmrl0l	10	2	frequently	frequently	RB
cord-276423-8rwmrl0l	10	3	documented	document	VBN
cord-276423-8rwmrl0l	10	4	,	,	,
cord-276423-8rwmrl0l	10	5	housing	housing	NN
cord-276423-8rwmrl0l	10	6	instability	instability	NN
cord-276423-8rwmrl0l	10	7	as	as	RB
cord-276423-8rwmrl0l	10	8	well	well	RB
cord-276423-8rwmrl0l	10	9	as	as	IN
cord-276423-8rwmrl0l	10	10	reduced	reduce	VBN
cord-276423-8rwmrl0l	10	11	access	access	NN
cord-276423-8rwmrl0l	10	12	to	to	IN
cord-276423-8rwmrl0l	10	13	health	health	NN
cord-276423-8rwmrl0l	10	14	care	care	NN
cord-276423-8rwmrl0l	10	15	and	and	CC
cord-276423-8rwmrl0l	10	16	recovery	recovery	NN
cord-276423-8rwmrl0l	10	17	support	support	NN
cord-276423-8rwmrl0l	10	18	services	service	NNS
cord-276423-8rwmrl0l	10	19	pose	pose	VBP
cord-276423-8rwmrl0l	10	20	an	an	DT
cord-276423-8rwmrl0l	10	21	additional	additional	JJ
cord-276423-8rwmrl0l	10	22	challenge	challenge	NN
cord-276423-8rwmrl0l	10	23	in	in	IN
cord-276423-8rwmrl0l	10	24	these	these	DT
cord-276423-8rwmrl0l	10	25	populations	population	NNS
cord-276423-8rwmrl0l	10	26	.	.	.
cord-276423-8rwmrl0l	11	1	Compared	compare	VBN
cord-276423-8rwmrl0l	11	2	to	to	IN
cord-276423-8rwmrl0l	11	3	the	the	DT
cord-276423-8rwmrl0l	11	4	general	general	JJ
cord-276423-8rwmrl0l	11	5	population	population	NN
cord-276423-8rwmrl0l	11	6	,	,	,
cord-276423-8rwmrl0l	11	7	people	people	NNS
cord-276423-8rwmrl0l	11	8	with	with	IN
cord-276423-8rwmrl0l	11	9	substance	substance	NN
cord-276423-8rwmrl0l	11	10	use	use	NN
cord-276423-8rwmrl0l	11	11	disorders	disorder	NNS
cord-276423-8rwmrl0l	11	12	are	be	VBP
cord-276423-8rwmrl0l	11	13	more	more	RBR
cord-276423-8rwmrl0l	11	14	likely	likely	JJ
cord-276423-8rwmrl0l	11	15	to	to	TO
cord-276423-8rwmrl0l	11	16	have	have	VB
cord-276423-8rwmrl0l	11	17	a	a	DT
cord-276423-8rwmrl0l	11	18	higher	high	JJR
cord-276423-8rwmrl0l	11	19	burden	burden	NN
cord-276423-8rwmrl0l	11	20	of	of	IN
cord-276423-8rwmrl0l	11	21	comorbid	comorbid	JJ
cord-276423-8rwmrl0l	11	22	medical	medical	JJ
cord-276423-8rwmrl0l	11	23	conditions	condition	NNS
cord-276423-8rwmrl0l	11	24	,	,	,
cord-276423-8rwmrl0l	11	25	and	and	CC
cord-276423-8rwmrl0l	11	26	it	-PRON-	PRP
cord-276423-8rwmrl0l	11	27	is	be	VBZ
cord-276423-8rwmrl0l	11	28	now	now	RB
cord-276423-8rwmrl0l	11	29	well	well	RB
cord-276423-8rwmrl0l	11	30	known	know	VBN
cord-276423-8rwmrl0l	11	31	that	that	IN
cord-276423-8rwmrl0l	11	32	people	people	NNS
cord-276423-8rwmrl0l	11	33	who	who	WP
cord-276423-8rwmrl0l	11	34	habitually	habitually	RB
cord-276423-8rwmrl0l	11	35	smoke	smoke	VBP
cord-276423-8rwmrl0l	11	36	or	or	CC
cord-276423-8rwmrl0l	11	37	vape	vape	VB
cord-276423-8rwmrl0l	11	38	tobacco	tobacco	NN
cord-276423-8rwmrl0l	11	39	and/or	and/or	CC
cord-276423-8rwmrl0l	11	40	cannabis	cannabis	NN
cord-276423-8rwmrl0l	11	41	are	be	VBP
cord-276423-8rwmrl0l	11	42	at	at	IN
cord-276423-8rwmrl0l	11	43	particular	particular	JJ
cord-276423-8rwmrl0l	11	44	risk	risk	NN
cord-276423-8rwmrl0l	11	45	of	of	IN
cord-276423-8rwmrl0l	11	46	experiencing	experience	VBG
cord-276423-8rwmrl0l	11	47	more	more	RBR
cord-276423-8rwmrl0l	11	48	unfavorable	unfavorable	JJ
cord-276423-8rwmrl0l	11	49	outcomes	outcome	NNS
cord-276423-8rwmrl0l	11	50	due	due	IN
cord-276423-8rwmrl0l	11	51	to	to	IN
cord-276423-8rwmrl0l	11	52	the	the	DT
cord-276423-8rwmrl0l	11	53	respiratory	respiratory	JJ
cord-276423-8rwmrl0l	11	54	and	and	CC
cord-276423-8rwmrl0l	11	55	pulmonary	pulmonary	JJ
cord-276423-8rwmrl0l	11	56	effects	effect	NNS
cord-276423-8rwmrl0l	11	57	of	of	IN
cord-276423-8rwmrl0l	11	58	SARS	SARS	NNP
cord-276423-8rwmrl0l	11	59	-	-	HYPH
cord-276423-8rwmrl0l	11	60	CoV2	CoV2	NNP
cord-276423-8rwmrl0l	11	61	(	(	-LRB-
cord-276423-8rwmrl0l	11	62	Berlin	Berlin	NNP
cord-276423-8rwmrl0l	11	63	,	,	,
cord-276423-8rwmrl0l	11	64	et	et	NNP
cord-276423-8rwmrl0l	11	65	al	al	NNP
cord-276423-8rwmrl0l	11	66	.	.	NNP
cord-276423-8rwmrl0l	11	67	,	,	,
cord-276423-8rwmrl0l	11	68	2020	2020	CD
cord-276423-8rwmrl0l	11	69	)	)	-RRB-
cord-276423-8rwmrl0l	11	70	.	.	.
cord-276423-8rwmrl0l	12	1	Immunocompromised	immunocompromise	VBN
cord-276423-8rwmrl0l	12	2	individuals	individual	NNS
cord-276423-8rwmrl0l	12	3	(	(	-LRB-
cord-276423-8rwmrl0l	12	4	like	like	IN
cord-276423-8rwmrl0l	12	5	those	those	DT
cord-276423-8rwmrl0l	12	6	due	due	JJ
cord-276423-8rwmrl0l	12	7	to	to	IN
cord-276423-8rwmrl0l	12	8	HIV	HIV	NNP
cord-276423-8rwmrl0l	12	9	infection	infection	NN
cord-276423-8rwmrl0l	12	10	)	)	-RRB-
cord-276423-8rwmrl0l	12	11	also	also	RB
cord-276423-8rwmrl0l	12	12	are	be	VBP
cord-276423-8rwmrl0l	12	13	in	in	IN
cord-276423-8rwmrl0l	12	14	increased	increase	VBN
cord-276423-8rwmrl0l	12	15	risk	risk	NN
cord-276423-8rwmrl0l	12	16	,	,	,
cord-276423-8rwmrl0l	12	17	and	and	CC
cord-276423-8rwmrl0l	12	18	a	a	DT
cord-276423-8rwmrl0l	12	19	considerable	considerable	JJ
cord-276423-8rwmrl0l	12	20	percentage	percentage	NN
cord-276423-8rwmrl0l	12	21	of	of	IN
cord-276423-8rwmrl0l	12	22	this	this	DT
cord-276423-8rwmrl0l	12	23	population	population	NN
cord-276423-8rwmrl0l	12	24	inject	inject	VBP
cord-276423-8rwmrl0l	12	25	drugs	drug	NNS
cord-276423-8rwmrl0l	12	26	.	.	.
cord-276423-8rwmrl0l	13	1	The	the	DT
cord-276423-8rwmrl0l	13	2	withdrawal	withdrawal	NN
cord-276423-8rwmrl0l	13	3	symptoms	symptom	NNS
cord-276423-8rwmrl0l	13	4	triggered	trigger	VBN
cord-276423-8rwmrl0l	13	5	during	during	IN
cord-276423-8rwmrl0l	13	6	social	social	JJ
cord-276423-8rwmrl0l	13	7	confinement	confinement	NN
cord-276423-8rwmrl0l	13	8	can	can	MD
cord-276423-8rwmrl0l	13	9	also	also	RB
cord-276423-8rwmrl0l	13	10	end	end	VB
cord-276423-8rwmrl0l	13	11	up	up	RP
cord-276423-8rwmrl0l	13	12	compromising	compromise	VBG
cord-276423-8rwmrl0l	13	13	these	these	DT
cord-276423-8rwmrl0l	13	14	measures	measure	NNS
cord-276423-8rwmrl0l	13	15	imposed	impose	VBN
cord-276423-8rwmrl0l	13	16	by	by	IN
cord-276423-8rwmrl0l	13	17	governments	government	NNS
cord-276423-8rwmrl0l	13	18	,	,	,
cord-276423-8rwmrl0l	13	19	leading	lead	VBG
cord-276423-8rwmrl0l	13	20	individuals	individual	NNS
cord-276423-8rwmrl0l	13	21	to	to	TO
cord-276423-8rwmrl0l	13	22	leave	leave	VB
cord-276423-8rwmrl0l	13	23	their	-PRON-	PRP$
cord-276423-8rwmrl0l	13	24	homes	home	NNS
cord-276423-8rwmrl0l	13	25	in	in	IN
cord-276423-8rwmrl0l	13	26	search	search	NN
cord-276423-8rwmrl0l	13	27	of	of	IN
cord-276423-8rwmrl0l	13	28	drugs	drug	NNS
cord-276423-8rwmrl0l	13	29	on	on	IN
cord-276423-8rwmrl0l	13	30	the	the	DT
cord-276423-8rwmrl0l	13	31	streets	street	NNS
cord-276423-8rwmrl0l	13	32	,	,	,
cord-276423-8rwmrl0l	13	33	potentially	potentially	RB
cord-276423-8rwmrl0l	13	34	increasing	increase	VBG
cord-276423-8rwmrl0l	13	35	their	-PRON-	PRP$
cord-276423-8rwmrl0l	13	36	exposure	exposure	NN
cord-276423-8rwmrl0l	13	37	to	to	IN
cord-276423-8rwmrl0l	13	38	the	the	DT
cord-276423-8rwmrl0l	13	39	virus	virus	NN
cord-276423-8rwmrl0l	13	40	.	.	.
cord-276423-8rwmrl0l	14	1	Being	be	VBG
cord-276423-8rwmrl0l	14	2	an	an	DT
cord-276423-8rwmrl0l	14	3	easily	easily	RB
cord-276423-8rwmrl0l	14	4	accessible	accessible	JJ
cord-276423-8rwmrl0l	14	5	substance	substance	NN
cord-276423-8rwmrl0l	14	6	,	,	,
cord-276423-8rwmrl0l	14	7	alcohol	alcohol	NN
cord-276423-8rwmrl0l	14	8	consumption	consumption	NN
cord-276423-8rwmrl0l	14	9	is	be	VBZ
cord-276423-8rwmrl0l	14	10	often	often	RB
cord-276423-8rwmrl0l	14	11	used	use	VBN
cord-276423-8rwmrl0l	14	12	to	to	TO
cord-276423-8rwmrl0l	14	13	cope	cope	VB
cord-276423-8rwmrl0l	14	14	with	with	IN
cord-276423-8rwmrl0l	14	15	negative	negative	JJ
cord-276423-8rwmrl0l	14	16	emotions	emotion	NNS
cord-276423-8rwmrl0l	14	17	.	.	.
cord-276423-8rwmrl0l	15	1	Present	present	JJ
cord-276423-8rwmrl0l	15	2	times	time	NNS
cord-276423-8rwmrl0l	15	3	of	of	IN
cord-276423-8rwmrl0l	15	4	uncertainty	uncertainty	NN
cord-276423-8rwmrl0l	15	5	may	may	MD
cord-276423-8rwmrl0l	15	6	lead	lead	VB
cord-276423-8rwmrl0l	15	7	to	to	IN
cord-276423-8rwmrl0l	15	8	an	an	DT
cord-276423-8rwmrl0l	15	9	increase	increase	NN
cord-276423-8rwmrl0l	15	10	in	in	IN
cord-276423-8rwmrl0l	15	11	alcohol	alcohol	NN
cord-276423-8rwmrl0l	15	12	misuse	misuse	NN
cord-276423-8rwmrl0l	15	13	,	,	,
cord-276423-8rwmrl0l	15	14	relapse	relapse	NN
cord-276423-8rwmrl0l	15	15	and	and	CC
cord-276423-8rwmrl0l	15	16	development	development	NN
cord-276423-8rwmrl0l	15	17	of	of	IN
cord-276423-8rwmrl0l	15	18	alcohol	alcohol	NN
cord-276423-8rwmrl0l	15	19	use	use	NN
cord-276423-8rwmrl0l	15	20	disorder	disorder	NN
cord-276423-8rwmrl0l	15	21	.	.	.
cord-276423-8rwmrl0l	16	1	This	this	DT
cord-276423-8rwmrl0l	16	2	can	can	MD
cord-276423-8rwmrl0l	16	3	lead	lead	VB
cord-276423-8rwmrl0l	16	4	to	to	IN
cord-276423-8rwmrl0l	16	5	physical	physical	JJ
cord-276423-8rwmrl0l	16	6	dependence	dependence	NN
cord-276423-8rwmrl0l	16	7	and	and	CC
cord-276423-8rwmrl0l	16	8	a	a	DT
cord-276423-8rwmrl0l	16	9	drastic	drastic	JJ
cord-276423-8rwmrl0l	16	10	restriction	restriction	NN
cord-276423-8rwmrl0l	16	11	on	on	IN
cord-276423-8rwmrl0l	16	12	access	access	NN
cord-276423-8rwmrl0l	16	13	to	to	IN
cord-276423-8rwmrl0l	16	14	alcohol	alcohol	NN
cord-276423-8rwmrl0l	16	15	can	can	MD
cord-276423-8rwmrl0l	16	16	lead	lead	VB
cord-276423-8rwmrl0l	16	17	to	to	IN
cord-276423-8rwmrl0l	16	18	life	life	NN
cord-276423-8rwmrl0l	16	19	-	-	HYPH
cord-276423-8rwmrl0l	16	20	threatening	threaten	VBG
cord-276423-8rwmrl0l	16	21	withdrawal	withdrawal	NN
cord-276423-8rwmrl0l	16	22	symptoms	symptom	NNS
cord-276423-8rwmrl0l	16	23	,	,	,
cord-276423-8rwmrl0l	16	24	as	as	RB
cord-276423-8rwmrl0l	16	25	well	well	RB
cord-276423-8rwmrl0l	16	26	as	as	IN
cord-276423-8rwmrl0l	16	27	an	an	DT
cord-276423-8rwmrl0l	16	28	increased	increase	VBN
cord-276423-8rwmrl0l	16	29	risk	risk	NN
cord-276423-8rwmrl0l	16	30	for	for	IN
cord-276423-8rwmrl0l	16	31	domestic	domestic	JJ
cord-276423-8rwmrl0l	16	32	violence	violence	NN
cord-276423-8rwmrl0l	16	33	.	.	.
cord-276423-8rwmrl0l	17	1	Alongside	alongside	IN
cord-276423-8rwmrl0l	17	2	isolation	isolation	NN
cord-276423-8rwmrl0l	17	3	itself	-PRON-	PRP
cord-276423-8rwmrl0l	17	4	,	,	,
cord-276423-8rwmrl0l	17	5	depression	depression	NN
cord-276423-8rwmrl0l	17	6	and	and	CC
cord-276423-8rwmrl0l	17	7	alcohol	alcohol	NN
cord-276423-8rwmrl0l	17	8	consumption	consumption	NN
cord-276423-8rwmrl0l	17	9	are	be	VBP
cord-276423-8rwmrl0l	17	10	risk	risk	NN
cord-276423-8rwmrl0l	17	11	factors	factor	NNS
cord-276423-8rwmrl0l	17	12	for	for	IN
cord-276423-8rwmrl0l	17	13	suicide	suicide	NN
cord-276423-8rwmrl0l	17	14	,	,	,
cord-276423-8rwmrl0l	17	15	which	which	WDT
cord-276423-8rwmrl0l	17	16	may	may	MD
cord-276423-8rwmrl0l	17	17	also	also	RB
cord-276423-8rwmrl0l	17	18	be	be	VB
cord-276423-8rwmrl0l	17	19	triggered	trigger	VBN
cord-276423-8rwmrl0l	17	20	by	by	IN
cord-276423-8rwmrl0l	17	21	unemployment	unemployment	NN
cord-276423-8rwmrl0l	17	22	and	and	CC
cord-276423-8rwmrl0l	17	23	other	other	JJ
cord-276423-8rwmrl0l	17	24	social	social	JJ
cord-276423-8rwmrl0l	17	25	/	/	SYM
cord-276423-8rwmrl0l	17	26	financial	financial	JJ
cord-276423-8rwmrl0l	17	27	stressors	stressor	NNS
cord-276423-8rwmrl0l	17	28	.	.	.
cord-276423-8rwmrl0l	18	1	In	in	IN
cord-276423-8rwmrl0l	18	2	addition	addition	NN
cord-276423-8rwmrl0l	18	3	,	,	,
cord-276423-8rwmrl0l	18	4	excessive	excessive	JJ
cord-276423-8rwmrl0l	18	5	alcohol	alcohol	NN
cord-276423-8rwmrl0l	18	6	consumption	consumption	NN
cord-276423-8rwmrl0l	18	7	may	may	MD
cord-276423-8rwmrl0l	18	8	lead	lead	VB
cord-276423-8rwmrl0l	18	9	to	to	IN
cord-276423-8rwmrl0l	18	10	a	a	DT
cord-276423-8rwmrl0l	18	11	weakened	weaken	VBN
cord-276423-8rwmrl0l	18	12	immune	immune	JJ
cord-276423-8rwmrl0l	18	13	system	system	NN
cord-276423-8rwmrl0l	18	14	,	,	,
cord-276423-8rwmrl0l	18	15	increasing	increase	VBG
cord-276423-8rwmrl0l	18	16	a	a	DT
cord-276423-8rwmrl0l	18	17	person	person	NN
cord-276423-8rwmrl0l	18	18	's	's	POS
cord-276423-8rwmrl0l	18	19	susceptibility	susceptibility	NN
cord-276423-8rwmrl0l	18	20	to	to	IN
cord-276423-8rwmrl0l	18	21	pneumonia	pneumonia	NN
cord-276423-8rwmrl0l	18	22	(	(	-LRB-
cord-276423-8rwmrl0l	18	23	Sarkar	Sarkar	NNP
cord-276423-8rwmrl0l	18	24	,	,	,
cord-276423-8rwmrl0l	18	25	et	et	NNP
cord-276423-8rwmrl0l	18	26	al	al	NNP
cord-276423-8rwmrl0l	18	27	.	.	NNP
cord-276423-8rwmrl0l	18	28	,	,	,
cord-276423-8rwmrl0l	18	29	2015	2015	CD
cord-276423-8rwmrl0l	18	30	)	)	-RRB-
cord-276423-8rwmrl0l	18	31	,	,	,
cord-276423-8rwmrl0l	18	32	making	make	VBG
cord-276423-8rwmrl0l	18	33	this	this	DT
cord-276423-8rwmrl0l	18	34	population	population	NN
cord-276423-8rwmrl0l	18	35	particularly	particularly	RB
cord-276423-8rwmrl0l	18	36	vulnerable	vulnerable	JJ
cord-276423-8rwmrl0l	18	37	to	to	IN
cord-276423-8rwmrl0l	18	38	COVID-19	COVID-19	NNP
cord-276423-8rwmrl0l	18	39	.	.	.
cord-276423-8rwmrl0l	19	1	In	in	IN
cord-276423-8rwmrl0l	19	2	order	order	NN
cord-276423-8rwmrl0l	19	3	to	to	TO
cord-276423-8rwmrl0l	19	4	also	also	RB
cord-276423-8rwmrl0l	19	5	deal	deal	VB
cord-276423-8rwmrl0l	19	6	with	with	IN
cord-276423-8rwmrl0l	19	7	anxiety	anxiety	NN
cord-276423-8rwmrl0l	19	8	and	and	CC
cord-276423-8rwmrl0l	19	9	insomnia	insomnia	NN
cord-276423-8rwmrl0l	19	10	during	during	IN
cord-276423-8rwmrl0l	19	11	this	this	DT
cord-276423-8rwmrl0l	19	12	period	period	NN
cord-276423-8rwmrl0l	19	13	,	,	,
cord-276423-8rwmrl0l	19	14	the	the	DT
cord-276423-8rwmrl0l	19	15	consumption	consumption	NN
cord-276423-8rwmrl0l	19	16	of	of	IN
cord-276423-8rwmrl0l	19	17	other	other	JJ
cord-276423-8rwmrl0l	19	18	drugs	drug	NNS
cord-276423-8rwmrl0l	19	19	,	,	,
cord-276423-8rwmrl0l	19	20	such	such	JJ
cord-276423-8rwmrl0l	19	21	as	as	IN
cord-276423-8rwmrl0l	19	22	benzodiazepines	benzodiazepine	NNS
cord-276423-8rwmrl0l	19	23	and	and	CC
cord-276423-8rwmrl0l	19	24	cannabis	cannabis	NN
cord-276423-8rwmrl0l	19	25	is	be	VBZ
cord-276423-8rwmrl0l	19	26	expected	expect	VBN
cord-276423-8rwmrl0l	19	27	to	to	TO
cord-276423-8rwmrl0l	19	28	occur	occur	VB
cord-276423-8rwmrl0l	19	29	.	.	.
cord-276423-8rwmrl0l	20	1	Although	although	IN
cord-276423-8rwmrl0l	20	2	benzodiazepines	benzodiazepine	NNS
cord-276423-8rwmrl0l	20	3	are	be	VBP
cord-276423-8rwmrl0l	20	4	legal	legal	JJ
cord-276423-8rwmrl0l	20	5	substances	substance	NNS
cord-276423-8rwmrl0l	20	6	usually	usually	RB
cord-276423-8rwmrl0l	20	7	prescribed	prescribe	VBN
cord-276423-8rwmrl0l	20	8	by	by	IN
cord-276423-8rwmrl0l	20	9	doctors	doctor	NNS
cord-276423-8rwmrl0l	20	10	,	,	,
cord-276423-8rwmrl0l	20	11	they	-PRON-	PRP
cord-276423-8rwmrl0l	20	12	represent	represent	VBP
cord-276423-8rwmrl0l	20	13	a	a	DT
cord-276423-8rwmrl0l	20	14	potential	potential	NN
cord-276423-8rwmrl0l	20	15	for	for	IN
cord-276423-8rwmrl0l	20	16	abuse	abuse	NN
cord-276423-8rwmrl0l	20	17	,	,	,
cord-276423-8rwmrl0l	20	18	and	and	CC
cord-276423-8rwmrl0l	20	19	their	-PRON-	PRP$
cord-276423-8rwmrl0l	20	20	excessive	excessive	JJ
cord-276423-8rwmrl0l	20	21	consumption	consumption	NN
cord-276423-8rwmrl0l	20	22	can	can	MD
cord-276423-8rwmrl0l	20	23	often	often	RB
cord-276423-8rwmrl0l	20	24	go	go	VB
cord-276423-8rwmrl0l	20	25	unnoticed	unnoticed	JJ
cord-276423-8rwmrl0l	20	26	.	.	.
cord-276423-8rwmrl0l	21	1	The	the	DT
cord-276423-8rwmrl0l	21	2	consumption	consumption	NN
cord-276423-8rwmrl0l	21	3	of	of	IN
cord-276423-8rwmrl0l	21	4	these	these	DT
cord-276423-8rwmrl0l	21	5	legal	legal	JJ
cord-276423-8rwmrl0l	21	6	drugs	drug	NNS
cord-276423-8rwmrl0l	21	7	is	be	VBZ
cord-276423-8rwmrl0l	21	8	particularly	particularly	RB
cord-276423-8rwmrl0l	21	9	prevalent	prevalent	JJ
cord-276423-8rwmrl0l	21	10	among	among	IN
cord-276423-8rwmrl0l	21	11	elderly	elderly	JJ
cord-276423-8rwmrl0l	21	12	patients	patient	NNS
cord-276423-8rwmrl0l	21	13	,	,	,
cord-276423-8rwmrl0l	21	14	who	who	WP
cord-276423-8rwmrl0l	21	15	represent	represent	VBP
cord-276423-8rwmrl0l	21	16	the	the	DT
cord-276423-8rwmrl0l	21	17	main	main	JJ
cord-276423-8rwmrl0l	21	18	age	age	NN
cord-276423-8rwmrl0l	21	19	-	-	HYPH
cord-276423-8rwmrl0l	21	20	risk	risk	NN
cord-276423-8rwmrl0l	21	21	group	group	NN
cord-276423-8rwmrl0l	21	22	for	for	IN
cord-276423-8rwmrl0l	21	23	COVID-19	covid-19	JJ
cord-276423-8rwmrl0l	21	24	infection	infection	NN
cord-276423-8rwmrl0l	21	25	,	,	,
cord-276423-8rwmrl0l	21	26	and	and	CC
cord-276423-8rwmrl0l	21	27	it	-PRON-	PRP
cord-276423-8rwmrl0l	21	28	is	be	VBZ
cord-276423-8rwmrl0l	21	29	important	important	JJ
cord-276423-8rwmrl0l	21	30	to	to	TO
cord-276423-8rwmrl0l	21	31	note	note	VB
cord-276423-8rwmrl0l	21	32	that	that	IN
cord-276423-8rwmrl0l	21	33	the	the	DT
cord-276423-8rwmrl0l	21	34	prevalence	prevalence	NN
cord-276423-8rwmrl0l	21	35	of	of	IN
cord-276423-8rwmrl0l	21	36	SUD	SUD	NNP
cord-276423-8rwmrl0l	21	37	in	in	IN
cord-276423-8rwmrl0l	21	38	this	this	DT
cord-276423-8rwmrl0l	21	39	population	population	NN
cord-276423-8rwmrl0l	21	40	has	have	VBZ
cord-276423-8rwmrl0l	21	41	been	be	VBN
cord-276423-8rwmrl0l	21	42	increasing	increase	VBG
cord-276423-8rwmrl0l	21	43	globally	globally	RB
cord-276423-8rwmrl0l	21	44	(	(	-LRB-
cord-276423-8rwmrl0l	21	45	Kuerbis	Kuerbis	NNP
cord-276423-8rwmrl0l	21	46	,	,	,
cord-276423-8rwmrl0l	21	47	et	et	NNP
cord-276423-8rwmrl0l	21	48	al	al	NNP
cord-276423-8rwmrl0l	21	49	.	.	NNP
cord-276423-8rwmrl0l	21	50	,	,	,
cord-276423-8rwmrl0l	21	51	2014	2014	CD
cord-276423-8rwmrl0l	21	52	)	)	-RRB-
cord-276423-8rwmrl0l	21	53	.	.	.
cord-276423-8rwmrl0l	22	1	Cannabis	cannabis	NN
cord-276423-8rwmrl0l	22	2	abuse	abuse	NN
cord-276423-8rwmrl0l	22	3	has	have	VBZ
cord-276423-8rwmrl0l	22	4	been	be	VBN
cord-276423-8rwmrl0l	22	5	proposed	propose	VBN
cord-276423-8rwmrl0l	22	6	as	as	IN
cord-276423-8rwmrl0l	22	7	a	a	DT
cord-276423-8rwmrl0l	22	8	precipitant	precipitant	NN
cord-276423-8rwmrl0l	22	9	of	of	IN
cord-276423-8rwmrl0l	22	10	psychotic	psychotic	JJ
cord-276423-8rwmrl0l	22	11	episodes	episode	NNS
cord-276423-8rwmrl0l	22	12	in	in	IN
cord-276423-8rwmrl0l	22	13	people	people	NNS
cord-276423-8rwmrl0l	22	14	with	with	IN
cord-276423-8rwmrl0l	22	15	schizophrenia	schizophrenia	NN
cord-276423-8rwmrl0l	22	16	and	and	CC
cord-276423-8rwmrl0l	22	17	capable	capable	JJ
cord-276423-8rwmrl0l	22	18	of	of	IN
cord-276423-8rwmrl0l	22	19	anticipating	anticipate	VBG
cord-276423-8rwmrl0l	22	20	the	the	DT
cord-276423-8rwmrl0l	22	21	onset	onset	NN
cord-276423-8rwmrl0l	22	22	of	of	IN
cord-276423-8rwmrl0l	22	23	disease	disease	NN
cord-276423-8rwmrl0l	22	24	development	development	NN
cord-276423-8rwmrl0l	22	25	.	.	.
cord-276423-8rwmrl0l	23	1	Potentially	potentially	RB
cord-276423-8rwmrl0l	23	2	aggravated	aggravate	VBN
cord-276423-8rwmrl0l	23	3	by	by	IN
cord-276423-8rwmrl0l	23	4	its	-PRON-	PRP$
cord-276423-8rwmrl0l	23	5	chronic	chronic	JJ
cord-276423-8rwmrl0l	23	6	use	use	NN
cord-276423-8rwmrl0l	23	7	,	,	,
cord-276423-8rwmrl0l	23	8	the	the	DT
cord-276423-8rwmrl0l	23	9	socalled	socalled	JJ
cord-276423-8rwmrl0l	23	10	cannabis	cannabis	NN
cord-276423-8rwmrl0l	23	11	amotivational	amotivational	NN
cord-276423-8rwmrl0l	23	12	syndrome	syndrome	NN
cord-276423-8rwmrl0l	23	13	refers	refer	VBZ
cord-276423-8rwmrl0l	23	14	to	to	IN
cord-276423-8rwmrl0l	23	15	lack	lack	NN
cord-276423-8rwmrl0l	23	16	of	of	IN
cord-276423-8rwmrl0l	23	17	motivation	motivation	NN
cord-276423-8rwmrl0l	23	18	,	,	,
cord-276423-8rwmrl0l	23	19	decline	decline	VBP
cord-276423-8rwmrl0l	23	20	in	in	IN
cord-276423-8rwmrl0l	23	21	functioning	function	VBG
cord-276423-8rwmrl0l	23	22	levels	level	NNS
cord-276423-8rwmrl0l	23	23	and	and	CC
cord-276423-8rwmrl0l	23	24	apathy	apathy	NN
cord-276423-8rwmrl0l	23	25	,	,	,
cord-276423-8rwmrl0l	23	26	a	a	DT
cord-276423-8rwmrl0l	23	27	condition	condition	NN
cord-276423-8rwmrl0l	23	28	with	with	IN
cord-276423-8rwmrl0l	23	29	a	a	DT
cord-276423-8rwmrl0l	23	30	predominance	predominance	NN
cord-276423-8rwmrl0l	23	31	of	of	IN
cord-276423-8rwmrl0l	23	32	negative	negative	JJ
cord-276423-8rwmrl0l	23	33	symptoms	symptom	NNS
cord-276423-8rwmrl0l	23	34	,	,	,
cord-276423-8rwmrl0l	23	35	which	which	WDT
cord-276423-8rwmrl0l	23	36	culminates	culminate	VBZ
cord-276423-8rwmrl0l	23	37	in	in	IN
cord-276423-8rwmrl0l	23	38	a	a	DT
cord-276423-8rwmrl0l	23	39	state	state	NN
cord-276423-8rwmrl0l	23	40	of	of	IN
cord-276423-8rwmrl0l	23	41	neglect	neglect	NN
cord-276423-8rwmrl0l	23	42	and	and	CC
cord-276423-8rwmrl0l	23	43	divestment	divestment	NN
cord-276423-8rwmrl0l	23	44	in	in	IN
cord-276423-8rwmrl0l	23	45	the	the	DT
cord-276423-8rwmrl0l	23	46	individual	individual	NN
cord-276423-8rwmrl0l	23	47	itself	-PRON-	PRP
cord-276423-8rwmrl0l	23	48	.	.	.
cord-276423-8rwmrl0l	24	1	Drug	drug	NN
cord-276423-8rwmrl0l	24	2	treatment	treatment	NN
cord-276423-8rwmrl0l	24	3	for	for	IN
cord-276423-8rwmrl0l	24	4	opioid	opioid	JJ
cord-276423-8rwmrl0l	24	5	use	use	NN
cord-276423-8rwmrl0l	24	6	disorders	disorder	NNS
cord-276423-8rwmrl0l	24	7	can	can	MD
cord-276423-8rwmrl0l	24	8	be	be	VB
cord-276423-8rwmrl0l	24	9	immediately	immediately	RB
cord-276423-8rwmrl0l	24	10	effective	effective	JJ
cord-276423-8rwmrl0l	24	11	and	and	CC
cord-276423-8rwmrl0l	24	12	life	life	NN
cord-276423-8rwmrl0l	24	13	-	-	HYPH
cord-276423-8rwmrl0l	24	14	saving	save	VBG
cord-276423-8rwmrl0l	24	15	,	,	,
cord-276423-8rwmrl0l	24	16	and	and	CC
cord-276423-8rwmrl0l	24	17	is	be	VBZ
cord-276423-8rwmrl0l	24	18	usually	usually	RB
cord-276423-8rwmrl0l	24	19	provided	provide	VBN
cord-276423-8rwmrl0l	24	20	in	in	IN
cord-276423-8rwmrl0l	24	21	an	an	DT
cord-276423-8rwmrl0l	24	22	outpatient	outpatient	NN
cord-276423-8rwmrl0l	24	23	setting	setting	NN
cord-276423-8rwmrl0l	24	24	.	.	.
cord-276423-8rwmrl0l	25	1	Since	since	IN
cord-276423-8rwmrl0l	25	2	it	-PRON-	PRP
cord-276423-8rwmrl0l	25	3	is	be	VBZ
cord-276423-8rwmrl0l	25	4	a	a	DT
cord-276423-8rwmrl0l	25	5	therapy	therapy	NN
cord-276423-8rwmrl0l	25	6	highly	highly	RB
cord-276423-8rwmrl0l	25	7	regulated	regulate	VBN
cord-276423-8rwmrl0l	25	8	by	by	IN
cord-276423-8rwmrl0l	25	9	health	health	NN
cord-276423-8rwmrl0l	25	10	authorities	authority	NNS
cord-276423-8rwmrl0l	25	11	,	,	,
cord-276423-8rwmrl0l	25	12	people	people	NNS
cord-276423-8rwmrl0l	25	13	with	with	IN
cord-276423-8rwmrl0l	25	14	opioid	opioid	JJ
cord-276423-8rwmrl0l	25	15	use	use	NN
cord-276423-8rwmrl0l	25	16	disorders	disorder	NNS
cord-276423-8rwmrl0l	25	17	may	may	MD
cord-276423-8rwmrl0l	25	18	face	face	VB
cord-276423-8rwmrl0l	25	19	even	even	RB
cord-276423-8rwmrl0l	25	20	greater	great	JJR
cord-276423-8rwmrl0l	25	21	challenges	challenge	NNS
cord-276423-8rwmrl0l	25	22	obtaining	obtain	VBG
cord-276423-8rwmrl0l	25	23	opioid	opioid	JJ
cord-276423-8rwmrl0l	25	24	agonist	agonist	NN
cord-276423-8rwmrl0l	25	25	treatment	treatment	NN
cord-276423-8rwmrl0l	25	26	,	,	,
cord-276423-8rwmrl0l	25	27	which	which	WDT
cord-276423-8rwmrl0l	25	28	should	should	MD
cord-276423-8rwmrl0l	25	29	be	be	VB
cord-276423-8rwmrl0l	25	30	considered	consider	VBN
cord-276423-8rwmrl0l	25	31	an	an	DT
cord-276423-8rwmrl0l	25	32	essential	essential	JJ
cord-276423-8rwmrl0l	25	33	treatment	treatment	NN
cord-276423-8rwmrl0l	25	34	during	during	IN
cord-276423-8rwmrl0l	25	35	the	the	DT
cord-276423-8rwmrl0l	25	36	COVID-19	covid-19	JJ
cord-276423-8rwmrl0l	25	37	pandemic	pandemic	NN
cord-276423-8rwmrl0l	25	38	(	(	-LRB-
cord-276423-8rwmrl0l	25	39	World	World	NNP
cord-276423-8rwmrl0l	25	40	Health	Health	NNP
cord-276423-8rwmrl0l	25	41	Organization	Organization	NNP
cord-276423-8rwmrl0l	25	42	,	,	,
cord-276423-8rwmrl0l	25	43	2020	2020	CD
cord-276423-8rwmrl0l	25	44	)	)	-RRB-
cord-276423-8rwmrl0l	25	45	.	.	.
cord-276423-8rwmrl0l	26	1	Greater	great	JJR
cord-276423-8rwmrl0l	26	2	flexibility	flexibility	NN
cord-276423-8rwmrl0l	26	3	in	in	IN
cord-276423-8rwmrl0l	26	4	dispensing	dispense	VBG
cord-276423-8rwmrl0l	26	5	take	take	VB
cord-276423-8rwmrl0l	26	6	-	-	HYPH
cord-276423-8rwmrl0l	26	7	home	home	NN
cord-276423-8rwmrl0l	26	8	medication	medication	NN
cord-276423-8rwmrl0l	26	9	,	,	,
cord-276423-8rwmrl0l	26	10	such	such	JJ
cord-276423-8rwmrl0l	26	11	as	as	IN
cord-276423-8rwmrl0l	26	12	providing	provide	VBG
cord-276423-8rwmrl0l	26	13	more	more	JJR
cord-276423-8rwmrl0l	26	14	than	than	IN
cord-276423-8rwmrl0l	26	15	one	one	CD
cord-276423-8rwmrl0l	26	16	dose	dose	NN
cord-276423-8rwmrl0l	26	17	of	of	IN
cord-276423-8rwmrl0l	26	18	methadone	methadone	NN
cord-276423-8rwmrl0l	26	19	at	at	IN
cord-276423-8rwmrl0l	26	20	a	a	DT
cord-276423-8rwmrl0l	26	21	time	time	NN
cord-276423-8rwmrl0l	26	22	due	due	JJ
cord-276423-8rwmrl0l	26	23	to	to	IN
cord-276423-8rwmrl0l	26	24	restrictions	restriction	NNS
cord-276423-8rwmrl0l	26	25	of	of	IN
cord-276423-8rwmrl0l	26	26	movement	movement	NN
cord-276423-8rwmrl0l	26	27	,	,	,
cord-276423-8rwmrl0l	26	28	in	in	IN
cord-276423-8rwmrl0l	26	29	combination	combination	NN
cord-276423-8rwmrl0l	26	30	with	with	IN
cord-276423-8rwmrl0l	26	31	isolated	isolate	VBN
cord-276423-8rwmrl0l	26	32	consumption	consumption	NN
cord-276423-8rwmrl0l	26	33	,	,	,
cord-276423-8rwmrl0l	26	34	increases	increase	VBZ
cord-276423-8rwmrl0l	26	35	vulnerability	vulnerability	NN
cord-276423-8rwmrl0l	26	36	to	to	TO
cord-276423-8rwmrl0l	26	37	relapse	relapse	NN
cord-276423-8rwmrl0l	26	38	and	and	CC
cord-276423-8rwmrl0l	26	39	overdose	overdose	NN
cord-276423-8rwmrl0l	26	40	,	,	,
cord-276423-8rwmrl0l	26	41	since	since	IN
cord-276423-8rwmrl0l	26	42	there	there	EX
cord-276423-8rwmrl0l	26	43	might	may	MD
cord-276423-8rwmrl0l	26	44	not	not	RB
cord-276423-8rwmrl0l	26	45	be	be	VB
cord-276423-8rwmrl0l	26	46	any	any	DT
cord-276423-8rwmrl0l	26	47	observers	observer	NNS
cord-276423-8rwmrl0l	26	48	who	who	WP
cord-276423-8rwmrl0l	26	49	can	can	MD
cord-276423-8rwmrl0l	26	50	administer	administer	VB
cord-276423-8rwmrl0l	26	51	naloxone	naloxone	NN
cord-276423-8rwmrl0l	26	52	to	to	TO
cord-276423-8rwmrl0l	26	53	reverse	reverse	VB
cord-276423-8rwmrl0l	26	54	them	-PRON-	PRP
cord-276423-8rwmrl0l	26	55	.	.	.
cord-276423-8rwmrl0l	27	1	There	there	EX
cord-276423-8rwmrl0l	27	2	is	be	VBZ
cord-276423-8rwmrl0l	27	3	also	also	RB
cord-276423-8rwmrl0l	27	4	evidence	evidence	NN
cord-276423-8rwmrl0l	27	5	of	of	IN
cord-276423-8rwmrl0l	27	6	increased	increase	VBN
cord-276423-8rwmrl0l	27	7	burden	burden	NN
cord-276423-8rwmrl0l	27	8	of	of	IN
cord-276423-8rwmrl0l	27	9	respiratory	respiratory	JJ
cord-276423-8rwmrl0l	27	10	diseases	disease	NNS
cord-276423-8rwmrl0l	27	11	in	in	IN
cord-276423-8rwmrl0l	27	12	people	people	NNS
cord-276423-8rwmrl0l	27	13	who	who	WP
cord-276423-8rwmrl0l	27	14	use	use	VBP
cord-276423-8rwmrl0l	27	15	illicit	illicit	JJ
cord-276423-8rwmrl0l	27	16	opioids	opioid	NNS
cord-276423-8rwmrl0l	27	17	,	,	,
cord-276423-8rwmrl0l	27	18	making	make	VBG
cord-276423-8rwmrl0l	27	19	this	this	DT
cord-276423-8rwmrl0l	27	20	is	be	VBZ
cord-276423-8rwmrl0l	27	21	group	group	NN
cord-276423-8rwmrl0l	27	22	especially	especially	RB
cord-276423-8rwmrl0l	27	23	vulnerable	vulnerable	JJ
cord-276423-8rwmrl0l	27	24	to	to	IN
cord-276423-8rwmrl0l	27	25	the	the	DT
cord-276423-8rwmrl0l	27	26	pandemic	pandemic	NN
cord-276423-8rwmrl0l	27	27	threat	threat	NN
cord-276423-8rwmrl0l	27	28	,	,	,
cord-276423-8rwmrl0l	27	29	as	as	IN
cord-276423-8rwmrl0l	27	30	there	there	EX
cord-276423-8rwmrl0l	27	31	is	be	VBZ
cord-276423-8rwmrl0l	27	32	an	an	DT
cord-276423-8rwmrl0l	27	33	increased	increased	JJ
cord-276423-8rwmrl0l	27	34	risk	risk	NN
cord-276423-8rwmrl0l	27	35	of	of	IN
cord-276423-8rwmrl0l	27	36	overdose	overdose	NN
cord-276423-8rwmrl0l	27	37	,	,	,
cord-276423-8rwmrl0l	27	38	since	since	IN
cord-276423-8rwmrl0l	27	39	these	these	DT
cord-276423-8rwmrl0l	27	40	substances	substance	NNS
cord-276423-8rwmrl0l	27	41	can	can	MD
cord-276423-8rwmrl0l	27	42	depress	depress	VB
cord-276423-8rwmrl0l	27	43	breathing	breathing	NN
cord-276423-8rwmrl0l	27	44	.	.	.
cord-276423-8rwmrl0l	28	1	In	in	IN
cord-276423-8rwmrl0l	28	2	some	some	DT
cord-276423-8rwmrl0l	28	3	patients	patient	NNS
cord-276423-8rwmrl0l	28	4	,	,	,
cord-276423-8rwmrl0l	28	5	particularly	particularly	RB
cord-276423-8rwmrl0l	28	6	those	those	DT
cord-276423-8rwmrl0l	28	7	with	with	IN
cord-276423-8rwmrl0l	28	8	personality	personality	NN
cord-276423-8rwmrl0l	28	9	disorders	disorder	NNS
cord-276423-8rwmrl0l	28	10	,	,	,
cord-276423-8rwmrl0l	28	11	substance	substance	NN
cord-276423-8rwmrl0l	28	12	use	use	NN
cord-276423-8rwmrl0l	28	13	reflects	reflect	VBZ
cord-276423-8rwmrl0l	28	14	the	the	DT
cord-276423-8rwmrl0l	28	15	difficulty	difficulty	NN
cord-276423-8rwmrl0l	28	16	in	in	IN
cord-276423-8rwmrl0l	28	17	processing	process	VBG
cord-276423-8rwmrl0l	28	18	feelings	feeling	NNS
cord-276423-8rwmrl0l	28	19	of	of	IN
cord-276423-8rwmrl0l	28	20	emptiness	emptiness	NN
cord-276423-8rwmrl0l	28	21	and	and	CC
cord-276423-8rwmrl0l	28	22	abandonment	abandonment	NN
cord-276423-8rwmrl0l	28	23	(	(	-LRB-
cord-276423-8rwmrl0l	28	24	which	which	WDT
cord-276423-8rwmrl0l	28	25	may	may	MD
cord-276423-8rwmrl0l	28	26	be	be	VB
cord-276423-8rwmrl0l	28	27	further	further	RB
cord-276423-8rwmrl0l	28	28	aggravated	aggravate	VBN
cord-276423-8rwmrl0l	28	29	due	due	IN
cord-276423-8rwmrl0l	28	30	to	to	IN
cord-276423-8rwmrl0l	28	31	quarantine	quarantine	NN
cord-276423-8rwmrl0l	28	32	and	and	CC
cord-276423-8rwmrl0l	28	33	imposed	impose	VBN
cord-276423-8rwmrl0l	28	34	social	social	JJ
cord-276423-8rwmrl0l	28	35	isolation	isolation	NN
cord-276423-8rwmrl0l	28	36	)	)	-RRB-
cord-276423-8rwmrl0l	28	37	,	,	,
cord-276423-8rwmrl0l	28	38	or	or	CC
cord-276423-8rwmrl0l	28	39	even	even	RB
cord-276423-8rwmrl0l	28	40	the	the	DT
cord-276423-8rwmrl0l	28	41	search	search	NN
cord-276423-8rwmrl0l	28	42	for	for	IN
cord-276423-8rwmrl0l	28	43	a	a	DT
cord-276423-8rwmrl0l	28	44	toxic	toxic	JJ
cord-276423-8rwmrl0l	28	45	state	state	NN
cord-276423-8rwmrl0l	28	46	that	that	WDT
cord-276423-8rwmrl0l	28	47	promotes	promote	VBZ
cord-276423-8rwmrl0l	28	48	an	an	DT
cord-276423-8rwmrl0l	28	49	internal	internal	JJ
cord-276423-8rwmrl0l	28	50	elevation	elevation	NN
cord-276423-8rwmrl0l	28	51	of	of	IN
cord-276423-8rwmrl0l	28	52	mood	mood	NN
cord-276423-8rwmrl0l	28	53	,	,	,
cord-276423-8rwmrl0l	28	54	promoting	promote	VBG
cord-276423-8rwmrl0l	28	55	greater	great	JJR
cord-276423-8rwmrl0l	28	56	harmony	harmony	NN
cord-276423-8rwmrl0l	28	57	and	and	CC
cord-276423-8rwmrl0l	28	58	pleasure	pleasure	NN
cord-276423-8rwmrl0l	28	59	.	.	.
cord-276423-8rwmrl0l	29	1	These	these	DT
cord-276423-8rwmrl0l	29	2	individuals	individual	NNS
cord-276423-8rwmrl0l	29	3	present	present	VBP
cord-276423-8rwmrl0l	29	4	a	a	DT
cord-276423-8rwmrl0l	29	5	behavioral	behavioral	JJ
cord-276423-8rwmrl0l	29	6	functioning	functioning	NN
cord-276423-8rwmrl0l	29	7	pattern	pattern	NN
cord-276423-8rwmrl0l	29	8	determined	determine	VBN
cord-276423-8rwmrl0l	29	9	by	by	IN
cord-276423-8rwmrl0l	29	10	instability	instability	NN
cord-276423-8rwmrl0l	29	11	and	and	CC
cord-276423-8rwmrl0l	29	12	an	an	DT
cord-276423-8rwmrl0l	29	13	intensely	intensely	RB
cord-276423-8rwmrl0l	29	14	disruptive	disruptive	JJ
cord-276423-8rwmrl0l	29	15	psychological	psychological	JJ
cord-276423-8rwmrl0l	29	16	conformation	conformation	NN
cord-276423-8rwmrl0l	29	17	,	,	,
cord-276423-8rwmrl0l	29	18	with	with	IN
cord-276423-8rwmrl0l	29	19	an	an	DT
cord-276423-8rwmrl0l	29	20	underlying	underlie	VBG
cord-276423-8rwmrl0l	29	21	hyper	hyper	NN
cord-276423-8rwmrl0l	29	22	-	-	NN
cord-276423-8rwmrl0l	29	23	responsiveness	responsiveness	NN
cord-276423-8rwmrl0l	29	24	to	to	IN
cord-276423-8rwmrl0l	29	25	stress	stress	NN
cord-276423-8rwmrl0l	29	26	.	.	.
cord-276423-8rwmrl0l	30	1	The	the	DT
cord-276423-8rwmrl0l	30	2	current	current	JJ
cord-276423-8rwmrl0l	30	3	pandemic	pandemic	NN
cord-276423-8rwmrl0l	30	4	crisis	crisis	NN
cord-276423-8rwmrl0l	30	5	has	have	VBZ
cord-276423-8rwmrl0l	30	6	also	also	RB
cord-276423-8rwmrl0l	30	7	led	lead	VBN
cord-276423-8rwmrl0l	30	8	to	to	IN
cord-276423-8rwmrl0l	30	9	the	the	DT
cord-276423-8rwmrl0l	30	10	interruption	interruption	NN
cord-276423-8rwmrl0l	30	11	of	of	IN
cord-276423-8rwmrl0l	30	12	psychotherapeutic	psychotherapeutic	JJ
cord-276423-8rwmrl0l	30	13	support	support	NN
cord-276423-8rwmrl0l	30	14	in	in	IN
cord-276423-8rwmrl0l	30	15	this	this	DT
cord-276423-8rwmrl0l	30	16	population	population	NN
cord-276423-8rwmrl0l	30	17	,	,	,
cord-276423-8rwmrl0l	30	18	which	which	WDT
cord-276423-8rwmrl0l	30	19	may	may	MD
cord-276423-8rwmrl0l	30	20	precipitate	precipitate	VB
cord-276423-8rwmrl0l	30	21	greater	great	JJR
cord-276423-8rwmrl0l	30	22	destabilization	destabilization	NN
cord-276423-8rwmrl0l	30	23	among	among	IN
cord-276423-8rwmrl0l	30	24	these	these	DT
cord-276423-8rwmrl0l	30	25	patients	patient	NNS
cord-276423-8rwmrl0l	30	26	on	on	IN
cord-276423-8rwmrl0l	30	27	a	a	DT
cord-276423-8rwmrl0l	30	28	daily	daily	JJ
cord-276423-8rwmrl0l	30	29	basis	basis	NN
cord-276423-8rwmrl0l	30	30	,	,	,
cord-276423-8rwmrl0l	30	31	leading	lead	VBG
cord-276423-8rwmrl0l	30	32	to	to	IN
cord-276423-8rwmrl0l	30	33	acting	acting	NN
cord-276423-8rwmrl0l	30	34	-	-	HYPH
cord-276423-8rwmrl0l	30	35	out	out	RP
cord-276423-8rwmrl0l	30	36	behaviors	behavior	NNS
cord-276423-8rwmrl0l	30	37	,	,	,
cord-276423-8rwmrl0l	30	38	with	with	IN
cord-276423-8rwmrl0l	30	39	an	an	DT
cord-276423-8rwmrl0l	30	40	increased	increase	VBN
cord-276423-8rwmrl0l	30	41	frequency	frequency	NN
cord-276423-8rwmrl0l	30	42	of	of	IN
cord-276423-8rwmrl0l	30	43	drug	drug	NN
cord-276423-8rwmrl0l	30	44	intoxications	intoxication	NNS
cord-276423-8rwmrl0l	30	45	and	and	CC
cord-276423-8rwmrl0l	30	46	substance	substance	NN
cord-276423-8rwmrl0l	30	47	consumption	consumption	NN
cord-276423-8rwmrl0l	30	48	.	.	.
cord-276423-8rwmrl0l	31	1	People	People	NNS
cord-276423-8rwmrl0l	31	2	who	who	WP
cord-276423-8rwmrl0l	31	3	started	start	VBD
cord-276423-8rwmrl0l	31	4	using	use	VBG
cord-276423-8rwmrl0l	31	5	drugs	drug	NNS
cord-276423-8rwmrl0l	31	6	as	as	IN
cord-276423-8rwmrl0l	31	7	a	a	DT
cord-276423-8rwmrl0l	31	8	way	way	NN
cord-276423-8rwmrl0l	31	9	to	to	TO
cord-276423-8rwmrl0l	31	10	help	help	VB
cord-276423-8rwmrl0l	31	11	with	with	IN
cord-276423-8rwmrl0l	31	12	their	-PRON-	PRP$
cord-276423-8rwmrl0l	31	13	suffering	suffering	NN
cord-276423-8rwmrl0l	31	14	caused	cause	VBN
cord-276423-8rwmrl0l	31	15	by	by	IN
cord-276423-8rwmrl0l	31	16	the	the	DT
cord-276423-8rwmrl0l	31	17	changes	change	NNS
cord-276423-8rwmrl0l	31	18	imposed	impose	VBN
cord-276423-8rwmrl0l	31	19	by	by	IN
cord-276423-8rwmrl0l	31	20	the	the	DT
cord-276423-8rwmrl0l	31	21	pandemic	pandemic	NN
cord-276423-8rwmrl0l	31	22	,	,	,
cord-276423-8rwmrl0l	31	23	as	as	RB
cord-276423-8rwmrl0l	31	24	well	well	RB
cord-276423-8rwmrl0l	31	25	as	as	IN
cord-276423-8rwmrl0l	31	26	those	those	DT
cord-276423-8rwmrl0l	31	27	who	who	WP
cord-276423-8rwmrl0l	31	28	already	already	RB
cord-276423-8rwmrl0l	31	29	used	use	VBD
cord-276423-8rwmrl0l	31	30	them	-PRON-	PRP
cord-276423-8rwmrl0l	31	31	or	or	CC
cord-276423-8rwmrl0l	31	32	accessed	access	VBN
cord-276423-8rwmrl0l	31	33	substance	substance	NN
cord-276423-8rwmrl0l	31	34	abuse	abuse	NN
cord-276423-8rwmrl0l	31	35	treatment	treatment	NN
cord-276423-8rwmrl0l	31	36	services	service	NNS
cord-276423-8rwmrl0l	31	37	may	may	MD
cord-276423-8rwmrl0l	31	38	be	be	VB
cord-276423-8rwmrl0l	31	39	particularly	particularly	RB
cord-276423-8rwmrl0l	31	40	at	at	IN
cord-276423-8rwmrl0l	31	41	risk	risk	NN
cord-276423-8rwmrl0l	31	42	during	during	IN
cord-276423-8rwmrl0l	31	43	the	the	DT
cord-276423-8rwmrl0l	31	44	current	current	JJ
cord-276423-8rwmrl0l	31	45	COVID-19	COVID-19	NNP
cord-276423-8rwmrl0l	31	46	pandemic	pandemic	NN
cord-276423-8rwmrl0l	31	47	.	.	.
cord-276423-8rwmrl0l	32	1	Usually	usually	RB
cord-276423-8rwmrl0l	32	2	,	,	,
cord-276423-8rwmrl0l	32	3	these	these	DT
cord-276423-8rwmrl0l	32	4	end	end	VBP
cord-276423-8rwmrl0l	32	5	up	up	RP
cord-276423-8rwmrl0l	32	6	constituting	constitute	VBG
cord-276423-8rwmrl0l	32	7	marginalized	marginalize	VBN
cord-276423-8rwmrl0l	32	8	groups	group	NNS
cord-276423-8rwmrl0l	32	9	,	,	,
cord-276423-8rwmrl0l	32	10	despite	despite	IN
cord-276423-8rwmrl0l	32	11	being	be	VBG
cord-276423-8rwmrl0l	32	12	present	present	JJ
cord-276423-8rwmrl0l	32	13	in	in	IN
cord-276423-8rwmrl0l	32	14	countries	country	NNS
cord-276423-8rwmrl0l	32	15	of	of	IN
cord-276423-8rwmrl0l	32	16	all	all	DT
cord-276423-8rwmrl0l	32	17	incomes	income	NNS
cord-276423-8rwmrl0l	32	18	,	,	,
cord-276423-8rwmrl0l	32	19	so	so	CC
cord-276423-8rwmrl0l	32	20	it	-PRON-	PRP
cord-276423-8rwmrl0l	32	21	is	be	VBZ
cord-276423-8rwmrl0l	32	22	urgent	urgent	JJ
cord-276423-8rwmrl0l	32	23	that	that	IN
cord-276423-8rwmrl0l	32	24	they	-PRON-	PRP
cord-276423-8rwmrl0l	32	25	be	be	VBP
cord-276423-8rwmrl0l	32	26	taken	take	VBN
cord-276423-8rwmrl0l	32	27	into	into	IN
cord-276423-8rwmrl0l	32	28	account	account	NN
cord-276423-8rwmrl0l	32	29	in	in	IN
cord-276423-8rwmrl0l	32	30	public	public	JJ
cord-276423-8rwmrl0l	32	31	health	health	NN
cord-276423-8rwmrl0l	32	32	strategies	strategy	NNS
cord-276423-8rwmrl0l	32	33	.	.	.
cord-276423-8rwmrl0l	33	1	Thus	thus	RB
cord-276423-8rwmrl0l	33	2	,	,	,
cord-276423-8rwmrl0l	33	3	considering	consider	VBG
cord-276423-8rwmrl0l	33	4	the	the	DT
cord-276423-8rwmrl0l	33	5	worldwide	worldwide	JJ
cord-276423-8rwmrl0l	33	6	reorganization	reorganization	NN
cord-276423-8rwmrl0l	33	7	of	of	IN
cord-276423-8rwmrl0l	33	8	mental	mental	JJ
cord-276423-8rwmrl0l	33	9	health	health	NN
cord-276423-8rwmrl0l	33	10	services	service	NNS
cord-276423-8rwmrl0l	33	11	,	,	,
cord-276423-8rwmrl0l	33	12	addiction	addiction	NN
cord-276423-8rwmrl0l	33	13	care	care	NN
cord-276423-8rwmrl0l	33	14	must	must	MD
cord-276423-8rwmrl0l	33	15	be	be	VB
cord-276423-8rwmrl0l	33	16	reinforced	reinforce	VBN
cord-276423-8rwmrl0l	33	17	,	,	,
cord-276423-8rwmrl0l	33	18	instead	instead	RB
cord-276423-8rwmrl0l	33	19	of	of	IN
cord-276423-8rwmrl0l	33	20	postponed	postpone	VBN
cord-276423-8rwmrl0l	33	21	,	,	,
cord-276423-8rwmrl0l	33	22	so	so	IN
cord-276423-8rwmrl0l	33	23	clinicians	clinician	NNS
cord-276423-8rwmrl0l	33	24	could	could	MD
cord-276423-8rwmrl0l	33	25	be	be	VB
cord-276423-8rwmrl0l	33	26	aware	aware	JJ
cord-276423-8rwmrl0l	33	27	of	of	IN
cord-276423-8rwmrl0l	33	28	signs	sign	NNS
cord-276423-8rwmrl0l	33	29	of	of	IN
cord-276423-8rwmrl0l	33	30	substance	substance	NN
cord-276423-8rwmrl0l	33	31	misuse	misuse	NN
cord-276423-8rwmrl0l	33	32	in	in	IN
cord-276423-8rwmrl0l	33	33	these	these	DT
cord-276423-8rwmrl0l	33	34	populations	population	NNS
cord-276423-8rwmrl0l	33	35	,	,	,
cord-276423-8rwmrl0l	33	36	considering	consider	VBG
cord-276423-8rwmrl0l	33	37	the	the	DT
cord-276423-8rwmrl0l	33	38	levels	level	NNS
cord-276423-8rwmrl0l	33	39	of	of	IN
cord-276423-8rwmrl0l	33	40	additional	additional	JJ
cord-276423-8rwmrl0l	33	41	stress	stress	NN
cord-276423-8rwmrl0l	33	42	they	-PRON-	PRP
cord-276423-8rwmrl0l	33	43	may	may	MD
cord-276423-8rwmrl0l	33	44	be	be	VB
cord-276423-8rwmrl0l	33	45	experiencing	experience	VBG
cord-276423-8rwmrl0l	33	46	.	.	.
cord-276423-8rwmrl0l	34	1	For	for	IN
cord-276423-8rwmrl0l	34	2	those	those	DT
cord-276423-8rwmrl0l	34	3	with	with	IN
cord-276423-8rwmrl0l	34	4	substance	substance	NN
cord-276423-8rwmrl0l	34	5	use	use	NN
cord-276423-8rwmrl0l	34	6	disorders	disorder	NNS
cord-276423-8rwmrl0l	34	7	,	,	,
cord-276423-8rwmrl0l	34	8	changes	change	NNS
cord-276423-8rwmrl0l	34	9	in	in	IN
cord-276423-8rwmrl0l	34	10	the	the	DT
cord-276423-8rwmrl0l	34	11	ability	ability	NN
cord-276423-8rwmrl0l	34	12	to	to	TO
cord-276423-8rwmrl0l	34	13	access	access	VB
cord-276423-8rwmrl0l	34	14	substances	substance	NNS
cord-276423-8rwmrl0l	34	15	and	and	CC
cord-276423-8rwmrl0l	34	16	their	-PRON-	PRP$
cord-276423-8rwmrl0l	34	17	treatments	treatment	NNS
cord-276423-8rwmrl0l	34	18	can	can	MD
cord-276423-8rwmrl0l	34	19	precipitate	precipitate	VB
cord-276423-8rwmrl0l	34	20	new	new	JJ
cord-276423-8rwmrl0l	34	21	crises	crisis	NNS
cord-276423-8rwmrl0l	34	22	.	.	.
cord-276423-8rwmrl0l	35	1	COVID-19	covid-19	VB
cord-276423-8rwmrl0l	35	2	and	and	CC
cord-276423-8rwmrl0l	35	3	Smoking	Smoking	NNP
cord-276423-8rwmrl0l	35	4	The	the	DT
cord-276423-8rwmrl0l	35	5	global	global	JJ
cord-276423-8rwmrl0l	35	6	burden	burden	NN
cord-276423-8rwmrl0l	35	7	of	of	IN
cord-276423-8rwmrl0l	35	8	disease	disease	NN
cord-276423-8rwmrl0l	35	9	attributable	attributable	JJ
cord-276423-8rwmrl0l	35	10	to	to	IN
cord-276423-8rwmrl0l	35	11	alcohol	alcohol	NN
cord-276423-8rwmrl0l	35	12	and	and	CC
cord-276423-8rwmrl0l	35	13	drug	drug	NN
cord-276423-8rwmrl0l	35	14	use	use	NN
cord-276423-8rwmrl0l	35	15	in	in	IN
cord-276423-8rwmrl0l	35	16	195	195	CD
cord-276423-8rwmrl0l	35	17	countries	country	NNS
cord-276423-8rwmrl0l	35	18	and	and	CC
cord-276423-8rwmrl0l	35	19	territories	territory	NNS
cord-276423-8rwmrl0l	35	20	,	,	,
cord-276423-8rwmrl0l	35	21	1990	1990	CD
cord-276423-8rwmrl0l	35	22	-	-	SYM
cord-276423-8rwmrl0l	35	23	2016	2016	CD
cord-276423-8rwmrl0l	35	24	:	:	:
cord-276423-8rwmrl0l	35	25	a	a	DT
cord-276423-8rwmrl0l	35	26	systematic	systematic	JJ
cord-276423-8rwmrl0l	35	27	analysis	analysis	NN
cord-276423-8rwmrl0l	35	28	for	for	IN
cord-276423-8rwmrl0l	35	29	the	the	DT
cord-276423-8rwmrl0l	35	30	Global	Global	NNP
cord-276423-8rwmrl0l	35	31	Burden	Burden	NNP
cord-276423-8rwmrl0l	35	32	of	of	IN
cord-276423-8rwmrl0l	35	33	Disease	Disease	NNP
cord-276423-8rwmrl0l	35	34	Study	Study	NNP
cord-276423-8rwmrl0l	35	35	2016	2016	CD
cord-276423-8rwmrl0l	35	36	.	.	.
cord-276423-8rwmrl0l	36	1	The	the	DT
cord-276423-8rwmrl0l	36	2	lancet	lancet	NN
cord-276423-8rwmrl0l	36	3	Substance	substance	NN
cord-276423-8rwmrl0l	36	4	Abuse	abuse	NN
cord-276423-8rwmrl0l	36	5	Among	among	IN
cord-276423-8rwmrl0l	36	6	Older	old	JJR
cord-276423-8rwmrl0l	36	7	Adults	Adults	NNPS
cord-276423-8rwmrl0l	36	8	Alcohol	Alcohol	NNP
cord-276423-8rwmrl0l	36	9	and	and	CC
cord-276423-8rwmrl0l	36	10	the	the	DT
cord-276423-8rwmrl0l	36	11	Immune	Immune	NNP
cord-276423-8rwmrl0l	36	12	System	System	NNP
cord-276423-8rwmrl0l	36	13	WHO	who	WP
cord-276423-8rwmrl0l	36	14	Model	Model	NNP
cord-276423-8rwmrl0l	36	15	Lists	Lists	NNPS
cord-276423-8rwmrl0l	36	16	of	of	IN
cord-276423-8rwmrl0l	36	17	Essential	Essential	NNP
cord-276423-8rwmrl0l	36	18	Medicines	medicine	NNS